Abstract Details

Title Gene Expression Signature for Predicting High Versus Low Risk of Future Autoimmune Central Nervous System Attack

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 155

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Richard Jones, MD (Zeneca Pharmaceuticals)	No disclosure on file
Daniel Phillips, MD (NEI of St. Louis)	No disclosure on file
Nicole Daneault, MD (Centre Hospitalier de L'Universite de Montreal)	No disclosure on file

��ɫ����